MktsMarkets

Humacyte, Inc.
NASDAQ: HUMAKey statistics
HUMA News
Stories mentioning HUMA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 495.00 | 467.00 | 753.00 | 301.00 | 517.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold | 2,038 | 9,082 | 260.00 | 213.00 | 147.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | (1,543) | (8,615) | 493.00 | 88.00 | 370.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 19,462 | 14,605 | 17,273 | 22,006 | 15,418 | 20,656 | 22,926 | 23,753 |
| Sales General & Admin | 7,610 | 7,809 | 8,136 | 7,307 | 5,746 | |||
| Total Operating Expenses | 28,088 | 30,233 | 29,499 | |||||
| Operating Income (Loss) | (28,935) | (30,836) | (24,390) | (29,727) | (23,184) | (28,088) | (30,233) | (29,499) |
| Interest Income | 330.00 | 503.00 | 590.00 | 832.00 | 662.00 | 852.00 | 911.00 | 1,310 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (17,619) | (24,804) | (17,510) | (37,658) | 39,139 | (20,940) | (39,202) | (56,663) |
| Earnings Per Share (Basic) | (0.09) | (0.16) | (0.11) | (0.24) | 0.28 | (0.18) | (0.33) | (0.48) |
| Earnings Per Share (Diluted) | (0.09) | (0.16) | (0.11) | (0.24) | 0.28 | (0.18) | (0.33) | (0.48) |
| Weighted Average Shares Outstanding (Basic) | 197,847 | 158,160 | 158,313 | 155,437 | 131,497 | 118,479 | 119,409 | 119,175 |
| Weighted Average Shares Outstanding (Diluted) | 197,847 | 158,160 | 158,313 | 155,437 | 131,759 | 118,479 | 119,409 | 119,175 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HUMA
Humacyte, Inc. (NASDAQ: HUMA) is a stock listed on the Nasdaq Stock Market under the ticker symbol HUMA. It last traded at $0.5500 (Nov 16, 2026, 11:11 AM ET), down 2.2% on the day. That gives Humacyte a market capitalisation of $155.1M.
Over the past 52 weeks HUMA has traded between $0.3400 and $1.52.
Revenue for the quarter ended Mar 31, 2026 was $495.0K; a net loss of $17.6M. Revenue was down 4.3% from $517.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $495.0K | -$17.6M | -3559.4% |
| Dec 31, 2025 | $467.0K | -$24.8M | -5311.3% |
| Sep 30, 2025 | $753.0K | -$17.5M | -2325.4% |
| Jun 30, 2025 | $301.0K | -$37.7M | -12511.0% |
From Humacyte’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…